Opendata, web and dolomites

T-CONTROL

Novel catheter to reduce Urinary Tract Infections (UTIs)

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 T-CONTROL project word cloud

Explore the words cloud of the T-CONTROL project. It provides you a very rough idea of what is the project "T-CONTROL" about.

feasibility    days    events    infection    hospitalization    eur    linked    muscle    stakeholders    thanks    guarantee    14    frequently    quality    alone    decline    business    sharp    ratification    bags    savings    uc    unmet    diapers    deaths    representing    urinary    hydrophobic    causing    revenues    ipr    interventions    route    professionals    plan    membrane    nursing    frequent    bn    solutions    substentially    stage    decreasing    made    market    injury    prescribers    spinal    conclude    life    workers    letters    16    previously    continence    assessing    patent    urine    catheter    develops    sheets    direct    health    commercializing    care    risk    14b    reduce    medical    special    acute    weak    competition    treatment    waste    emergency    channels    approval    incontinence    sl    safety    investment    29    financial    gloves    innovative    introduction    raised    cord    investments    foreseeing    material    mentioned    patients    indwelling    customers    retention    rethink    catheters    mainly    difference    t    visits    hospitals    sme    custom    hypertrophy    additional    pave    prostate    million   

Project "T-CONTROL" data sheet

The following table provides information about the project.

Coordinator
RETHINK MEDICAL SL 

Organization address
address: C/ PRACTICANTE IGNACIO RODRIGUEZ S/N - EDIFICIO PO II DEL CAMPUS UNIVERSITARIO DE TAFIRA
city: LAS PALMAS DE GRAN CANARIA
postcode: 35017
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://www.rethinkmedical.es
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-08-01   to  2018-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    RETHINK MEDICAL SL ES (LAS PALMAS DE GRAN CANARIA) coordinator 50˙000.00

Map

 Project objective

T-Control is an innovative indwelling urinary catheter. Urinary Catheters (UC) are one of the most frequently used medical devices on the market. They are used during medical interventions and treatment, as well as incontinence or urine retention in case of spinal cord injury, prostate hypertrophy, weak muscle, and many other conditions.

There are several unmet needs related to currently used catheters. They cause a sharp decline of quality of life of the patients, are linked to frequent emergency visits and increase substentially the risk of infection both for patients and health care professionals. There are about 1,3 million cases in EU, causing 1,8 bn EUR direct cost and more than 14,000 deaths.

T-Control is addressing all the previously mentioned problems thanks to its novel design and a special hydrophobic membrane material, with patent approval both in EU and US, developed after 4 years of R&D.

T-Control will reduce additional days of hospitalization (leading to €1.14B savings in EU alone), but also guarantee the safety of health workers and decreasing continence related waste (sheets, gloves, diapers, catheters, bags…) representing around 29% of medical waste in non-acute hospitals.

Rethink Medical SL develops new medical solutions, mainly linked to nursing. It raised the interest of 16 stakeholders on the market (Letters of Support).

The feasibility study (SME Phase 1) shall address a financial plan, foreseeing all the costs and investments associated with commercializing our custom-made UC and the expected revenues. The study will also aim at assessing other important aspects such as IPR management, determine the best investment route for the growth stage, and conclude the best channels to reach customers and how we can best explain our difference from competition (prescribers, events, hospitals…). All these activities will lead to the ratification of a detailed business plan that will pave the way towards an effective market introduction.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "T-CONTROL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "T-CONTROL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

TAPPXSSAI (2019)

Development of a system for automatic ad insertion into on-demand streaming video to provide new monetization mechanisms to the media industry

Read More  

COUNTMITMENT (2019)

NATURAL CAPITAL ACCOUNTANCY TO IMPROVE REPORTING AND ENVIRONMENTAL PERFORMANCE

Read More  

EVERCAM (2020)

Intelligent Vision System for Improved Communication and Higher Productivity in Construction

Read More